Evidence-Based Cannabis Medicine: Insights from Global Clinical Research
- GREEN CAVE

- Nov 20, 2025
- 1 min read
Updated: Nov 20, 2025
We are pleased to present a scientific overview of the research conducted by Dr. Lihi Bar-Lev Schleider, a clinical researcher with over 17 years of experience in medical cannabis studies. Her work includes large-scale real-world patient data analyses and several randomized placebo-controlled clinical trials conducted in collaboration with hospitals, research institutes and clinical partners internationally.
Dr. Bar-Lev Schleider’s research focuses on evidence-based evaluation of cannabinoids across a range of clinical domains, including:
neurological and neurodevelopmental conditions
chronic and neuropathic pain
PTSD and trauma-related symptoms
inflammatory and autoimmune disorders
Her studies have contributed to a clearer understanding of patient outcomes, safety considerations, and therapeutic response patterns in real-world and controlled clinical settings.

Why this research matters
As medical cannabis enters a more regulated and clinically oriented era, healthcare professionals and industry partners increasingly rely on validated, scientifically grounded information.
Evidence-based data — rather than commercial claims — are essential for guiding safe, responsible and compliant medical-cannabis practices.
At Green Cave, we are committed to sharing educational, non-commercial and regulation-aligned scientific content to support Thailand’s evolving medical-cannabis ecosystem and the global community of clinicians, researchers and B2B professionals.
To explore more of Dr. Bar-Lev Schleider’s research and publications:
Are you a licensed clinic or dispensary in Thailand looking for consistent, medical-grade GACP strains? We support regulated B2B supply only.
Yes — we are sourcing GACP medical cannabis
Yes — we need a compliant B2B supplier in Thailand
Not yet — but evaluating medical cannabis partners
.png)

Comments